ArticleFrontiers in pharmacology2026

The impact of China's drug regulatory reform on access to orphan drugs: a cross-sectional study of diseases listed in the rare disease catalog.

Yipeng Lan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.